Medicare Meets CBD: A new Medicare pilot will cover hemp-derived CBD for certain patients, even as Congress moves toward a law that could effectively remove many hemp-derived THC products from the market—creating a policy clash that could disrupt patient access and the industry. Hemp Industry Shockwave: A new economic report warns a Dec. 11 ban on hemp-derived THC products could shut down about 68% of U.S. hemp-related businesses, underscoring how fast rules can hit supply chains. Caregiver Strain: New survey data finds 7 in 10 carers say a loved one’s chronic illness has harmed their mental health, with many reporting anxiety, isolation, and lost personal time. Regulation Pressure on Kratom: Coverage highlights rising kratom/7-OH exposure reports and growing enforcement moves, as doctors weigh the risk of bans for current users. Cannabis Court/Enforcement: UK reporting details a jailed man tied to a cannabis farm after police found plants and equipment; Malaysia court updates show prosecutors seeking to serve an appeal notice in a cannabis trafficking case. CBD in Consumer Culture: Kendall Jenner buys into Trip, a CBD drinks brand, signaling mainstream marketing momentum for hemp-derived wellness products. Medical Cannabis Supply: Dunbar Pharma says it will showcase its plant-derived dronabinol API capabilities at expopharm 2026 in Munich.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Clinical Trial Update (Australia): Avecho’s independent monitoring board reviewed unblinded interim data from its pivotal cannabidiol insomnia trial and unanimously backed continuing recruitment at the original participant size, with the company restarting final-stage enrollment and securing a long-term exclusive generics license deal covering Australian commercial rights. Regulatory Pathway (Autism): Neurotech International says its registrational autism program is in pivotal recruitment, with a U.S. regulatory clearance opening a parallel dosing study that could support a single evidence package across jurisdictions. Care Delivery Expansion (Mental Health): Emyria extended its Empax clinic network across mainland states, including western Sydney, supported by a private health insurance reimbursement pathway rather than purely out-of-pocket demand. Policy & Governance (Colombia): A new study maps how medicinal cannabis research can be translated into workable policy, linking evidence with Ministry of Health decision-making on access rules and psychoactive limits. Hemp THC Retail (U.S.): Convenience stores are pushing for a regulatory alternative after a federal delay on a hemp THC ban, arguing existing age-verification systems can support legal sales. Cybersecurity (U.S./Canada): An FBI probe follows reports of massive driver’s license data exposure tied to an ID verification firm, raising risks for fraud that can hit regulated cannabis businesses too.
Medical Cannabis Markets: Canopy Growth reported fiscal Q1 revenue up 13% to $58.9M, with gains in Canadian medical (+22%), adult-use (+10%) and international (+10%), but investors barely moved as losses and cash burn remain. Harm-Reduction Policy: Switzerland’s pharmacy cannabis pilot (Bern, Biel, Lucerne) says legal access hasn’t increased consumption; interim findings point to safer use trends like vaping, and the program runs to Oct. 2028. Animal CBD Product Launch: Votum Labs’ SOS by Happy Pets released a CBD spray for fireworks and travel anxiety, claiming THC-free calming without sedation. Medical/Regulatory Watch: Ohio’s higher-ed and commerce agencies are urging families to talk about “informed cannabis decisions” as students return to campus. Industry Risk (US Hemp THC): A retailer warns federal hemp-definition changes could upend late-2026 hemp-derived THC rules unless Congress delays or replaces the approach. Clinical Safety Debate: A new discussion highlights uncertainty around marijuana smoke and lung cancer risk, focusing on cannabis use disorder findings and why causation is hard to pin down.
Hemp policy fight: North Carolina’s hemp-derived THC industry is in a high-stakes showdown as a hemp coalition (CBHD) pushes Winston-Salem and Raleigh to rethink cannabis rules amid a looming federal crackdown. Medical access model: Utah’s medical cannabis pharmacies are being framed as a blueprint for a future federally regulated Schedule III market, with pharmacists required to counsel on dosing and interactions. Regulatory timeline: Texas is tightening enforcement on delta-8/other THC gummies, with a felony exposure shift tied to how products are classified and weighed. Public safety & enforcement: Zambia’s Drug Enforcement Commission reports cannabis seizures and arrests in intelligence-led operations, underscoring ongoing cross-border pressure on illicit markets. Research angle: A Johns Hopkins study is testing THC’s effects in a way that’s being discussed alongside sleep and insomnia management claims. Hemp in everyday life: Australia’s first “living coffin” uses mycelium plus upcycled hemp fibres, adding a feel-good, non-medical hemp use story to the week’s mix.
Hemp policy showdown (Virginia): A federal judge is being asked to slow Virginia’s hemp law after a lawsuit argues it violates the U.S. Constitution by effectively banning “intoxicating” hemp products sold statewide. Local cannabis zoning (Minnesota): Faribault County commissioners reversed course and approved a cannabis microbusiness conditional use permit, adding a 12-foot fence requirement after earlier concerns about proximity to a family with young children. Medical hemp safety alert (Canada): Membertou Health Centre issued a community drug alert after cannabis in the area tested positive for fentanyl, offering drug testing strips and naloxone kits. Enforcement & supply chain (Philippines): The Philippine Coast Guard is seeking access to a yacht tied to suspected drug smuggling routes, requesting logbooks and navigation data while the vessel is held by customs. Research/health (alcohol use disorder): A new study reports semaglutide didn’t cut core alcohol craving or drinks per day in a lab setting, but did reduce heavy drinking days and related harms. Cannabis in the spotlight (sports): US Open champion Aryna Sabalenka complained about marijuana smell during her match, urging better awareness around tennis courts.
US Open & public behavior: Aryna Sabalenka complained about a strong marijuana smell during her third-round win, asking fans not to smoke near tennis courts. Law enforcement & seizures: Texas DPS troopers used K-9 “Karma” to seize 133 pounds of marijuana and $6,804 in suspected proceeds during a traffic stop. Criminal cases tied to cannabis: A Royal Mail worker in the UK was jailed for diverting drug parcels, with police finding about £1.2m in cash linked to cannabis supply. Maritime drug probe: The Philippine Coast Guard is seeking access to the sailing yacht “Lindsy” to review voyage logs and navigation data for possible routes used to move illegal drugs. Local court fallout: In Maryland, a man’s ammunition case cited a prior conviction for cannabis-related intent to distribute. Sports culture ripple: The “weed smell” issue is also showing up in broader tennis chatter, with other players previously raising similar complaints.
Maritime Drug Probe: The Philippine Coast Guard is seeking access to the sailing yacht “Lindsy,” currently held by customs, to review logbooks and navigation data as part of an ongoing investigation into possible drug routes. Sports & Public Health: At the U.S. Open, Aryna Sabalenka said the smell of marijuana from the crowd disrupted her play, urging fans to avoid smoking near tennis courts. Enforcement at Airports: Hong Kong Customs seized about 12 kg of suspected cannabis buds at the airport, arresting three Mainland passengers after concealment was found in checked and carry-on luggage. Legal Case Spotlight: A Bermuda trial heard claims that a Canadian “exotic entertainer” imported nearly 13 kg of cannabis after customs scanned her bag and found heat-sealed packages. Road Safety Messaging: Illinois police and DOT are running Labor Day impaired-driving enforcement, explicitly warning that impairment from drugs—including cannabis—puts everyone at risk. Treatment Capacity Strain: Nigeria’s Jos University Teaching Hospital says psychiatric demand is rising faster than beds, leaving families waiting in emergency units for admissions.
Federal Hemp Policy: A Trump-signed continuing resolution delays most upcoming federal hemp restrictions on “total THC” rules until Dec. 11, giving retailers and hemp THC product sellers a short reprieve while lawmakers keep negotiating. Sports & Public Health: At the U.S. Open, Aryna Sabalenka said the smell of marijuana bothered her during a third-round win, asking fans to avoid smoking near courts; no smokers were found or ejected. Legal/Enforcement: Nebraska’s Supreme Court rejected efforts to void medical marijuana legalization measures, upholding voter-approved rules. Industry & Markets: Curaleaf opened a new Boston store, reigniting debate over neighborhood saturation and social equity impacts. Courts & Synthetic Cannabinoids: Former Alabama player Darius Miles faces new jail-related charges after staff allegedly found synthetic marijuana “paper route” in his belongings. Security & IDs: FBI probes a dark-web claim tied to 153M+ driver’s license scans, with a reported link to an identity verification provider that also serves cannabis clients.
Regulatory clarity for CBD foods: The UK Food Standards Agency is set to recommend authorising three high-purity CBD “novel foods” (synthetic CBD and two CBD isolates), with proposed limits like 10mg daily intake and warnings for vulnerable groups—moving the market closer to formal approval. Hemp THC policy delay: A U.S. House continuing resolution would push back a federal ban on hemp-derived THC gummies and drinks, buying more time for lawmakers to craft rules. Medical access expansion: Trulieve announced a new medical cannabis dispensary opening in Dunwoody, Georgia, expanding product formats for patients across Metro Atlanta. School safety tech: Hillsborough County schools are expanding vaping sensors to middle schools and K-8 bathrooms, with alerts for vapor from nicotine and marijuana products (no cameras or audio). Supply chain/consumer risk: Colorado regulators faced criticism after slow safety warnings for a marijuana sleep aid linked to liver injury—highlighting gaps in consumer protection. Industry deal: cbdMD agreed to buy Twinlab brands, aiming to boost revenue and distribution. Public health & harm context: A Cloquet community event will raise awareness after a teen’s death was attributed to kratom toxicity, despite a THC-positive test. Data security shock: The FBI is investigating a dark-web listing claiming 153M+ driver’s license scans, with reports tying some exposure to dispensary ID scanning.
Impaired Driving & Public Health: A new study in JAMA Network Open finds cannabis edibles can impair driving (lane control, reaction time, speed consistency) even when blood THC stays below common roadside cutoffs, raising enforcement concerns. Child Safety: Poison control data show a sharp rise in kids’ unintentional recreational drug ingestions over 25 years, driven largely by cannabis edibles; researchers urge calling 1-800-222-1222 instead of inducing vomiting. School Safety Tech: Hillsborough County, Florida is expanding vaping detectors to middle and K-8 campuses; the sensors can flag vapor from multiple substances, including marijuana, and alert staff without recording audio/video. Retail & Regulation: California’s Cannabis Advisory Committee will meet Sept. 15 to discuss federal rescheduling and supply-chain payment issues. Enforcement & Seizures: India reports a 600 kg ganja seizure in Anakapalli; Malaysia says overseas detainees helped it map cross-border drug networks. Legal/Industry: New Zealand sentencing in “Operation Van” targets a Rotorua-linked meth syndicate manager, underscoring broader drug-crackdown momentum.
Cross-Border Enforcement: Malaysia says a detained man in India helped police map a wider hydroponic cannabis trafficking network, with authorities tightening airport entry checks after the Aug. 31 seizure of 3.452 kg. Global Supply Chain Crime: Hong Kong Customs arrested a passenger after finding about 3 kg of suspected cannabis buds hidden in carry-on baggage at the airport. Medical-Industry Business Watch: Curaleaf executives will meet investors at an upcoming Sept. 9 conference in New York, signaling continued focus on medical and consumer cannabis markets. Hemp-Derived THC Policy Push: A Lenox native now leading Edibles.com says he’s lobbying Congress to keep low-dose hemp-derived THC products legal as federal rules shift. Public Health & Marketing: A Washington State University study finds cannabis ads framed around “better sex” can shape young adults’ expectations and intentions to use cannabis before sex. Local Retail Spotlight: A new downtown dispensary, Locals Cannabis, emphasizes guided consultations and product education for both new and returning customers.
Medical Cannabis Policy Moves: San Diego County supervisors voted 3-2 to formally OK a “socially equitable” cannabis policy for unincorporated areas, expanding cultivation, distribution, manufacturing, retail, events, and testing while tightening rules like outdoor cultivation limits and buffers. Enforcement & Public Safety: Mendocino County Sheriff’s Office is set to receive $4.5M to target illegal cannabis grows, with plans for detectives, night vision gear, and drones amid claims illegal sites fuel violence. Market Reality Check: Oklahoma’s medical marijuana boom has collapsed, with licensed grows down about 85% and only a fraction of growers still operating as crackdowns reshape the industry. Research & Treatment Angle: A lab study reports ultra-low THC doses may keep breast cancer cells in a less aggressive state by reducing invasiveness and tumor-initiating traits. Patient Behavior in Heat: A NuggMD survey finds half of medical cannabis users stick with flower/smoking in summer, with vapes next at 24%, suggesting familiarity still drives choices. Corporate Deal Watch: Cresco Labs closed a $50M purchase of nine Pennsylvania medical dispensaries, expanding its retail footprint in a major medical market. Cybersecurity Risk: The FBI is investigating a dark-web service allegedly selling scans of 153M+ U.S./Canadian driver’s licenses, highlighting how “verification” systems can expose sensitive health-related IDs too.
CBD & Corporate Deals: cbdMD signed a definitive agreement to acquire Twinlab brands (Twinlab, Reserveage, Metabolife, Alvita Tea) via an asset purchase deal tied to a court process, aiming to stabilize legacy supplement lines and reduce revenue concentration in hemp as regulatory risk shifts. Medical Cannabis Markets: Aurora Cannabis urged shareholders to reject Curaleaf’s hostile bid, arguing it undervalues Aurora and could weaken shareholder rights, while Aurora’s board recommends shareholders take no action. Regulation & Policy: The U.S. House passed a stopgap funding bill to delay a shutdown and, separately, Congress approved a measure delaying a hemp THC product ban by four weeks—keeping the policy fight alive. Research & Drug Development: SciSparc’s NeuroThera Labs is pursuing FDA Orphan Drug Designation for its adult Tourette Syndrome candidate, engaging a U.S. government affairs firm to boost visibility with federal stakeholders. Industry & Products: Cronos expanded Spinach® edibles and vapes, launching new flavors and a live-resin gummy in its SOURZ by Spinach® lineup. Legal & Safety: A Missouri Christian youth home faces federal abuse lawsuits alleging forced labor and sexual abuse, while an Ontario doctor was suspended for ketamine prescribing practices that included asking patients to waive rights to sue or complain.
Hemp policy showdown: The House passed a stopgap spending bill that delays a federal ban on hemp-derived THC products by about four weeks, pushing the deadline to Dec. 12 and giving the industry a short runway to negotiate. Regulatory pressure on cannabis: A New Mexico court paused a legal fight over the state’s new seed-to-sale cannabis tracking system, after owners said the rollout could disrupt transport if the system fails. DEA rescheduling fight: In the DEA marijuana rescheduling hearing, the agency argued marijuana should move off Schedule I, while multiple groups pushed to keep it there—leaving the final outcome tied to which medical-use test applies. Medical hemp research & care: An NIH-funded trial found a virtual prevention program (TACUNA) reduced substance use and anxiety among urban American Indian and Alaska Native emerging adults, highlighting culturally grounded approaches. Public health and impairment: California CHP warned that cannabis can impair driving and ran Labor Day enforcement messaging alongside alcohol-focused campaigns. Hemp in agriculture: Oregon State University tested a first-of-its-kind hemp harvest machine at its Klamath Basin research center, signaling continued momentum for U.S. hemp production.
US Hemp THC Ban Delay in Stopgap Fight: House GOP leaders are scrambling over a stopgap funding bill that includes a one-month delay on a federal ban for intoxicating hemp THC products, with some Republicans threatening to block the procedural path even as the fast-track approach could still move the bill forward. Medical Testing & Workplace Screening Tech: Intelligent Bio Solutions says its non-invasive drug screening system hit 98%+ accuracy for codeine in a multi-site method comparison study, and it also announced a ~$5M private placement to support its FDA 510(k) program. Non-Opioid Pain Pipeline: MIRA Pharmaceuticals reported positive 7-day dose-range toxicology results for oral candidate MIRA-55 in rats and dogs, advancing its IND-enabling work for inflammatory pain. Cannabis Policy & Product Safety: Ohio’s DUI enforcement push highlights marijuana impairment concerns as legal retail sales expand, while a separate report notes cannabis edibles can impair driving even below drug-driving limits. Health Research: A large study links recreational drug use to higher stroke risk, including cannabis (37% higher risk), adding to the growing debate over preventable substance-related health harms.
Medical Access & Safety: Maine is rolling out 12,000 free lockable cannabis storage bags through 140+ retailers and public health advocates, with one bag available to eligible medical patients (18+) and adult-use consumers (21+) as supplies last—aimed at keeping products out of reach of kids and pets. CBD/Clinical Research: SciSparc’s NeuroThera says enrollment is progressing in its SCI-210 autism trial in Israel, using a CBD + CannAmide formulation (26 children enrolled so far toward a 60-child goal). Policy & Regulation: California Gov. Newsom signed legislation (AB 2249) tightening standards for cannabis packaging/labels/ads that appeal to children, following a state auditor review. Industry & Community: MAPS (psychedelics) announced its first partnership with a New Jersey cannabis operator for store activations, signaling more crossover between cannabinoid and psychedelic worlds. Public Health Context: A narrative review finds human data on whether cannabis use changes breast milk nutrients/immune components is still sparse and inconclusive. Enforcement & Risk: A domestic dispute in Indiana led to discovery of suspected synthetic cannabinoids and marijuana in a home with children.
Federal cannabinoid policy shift: Endovia Health Sciences says the U.S. government’s position in DEA hearings supports moving marijuana from Schedule I to Schedule III, framing it as a clearer path for cannabinoid medicines and a stronger regulatory runway. Pediatric cannabis poisoning: Two young children in Jerusalem were hospitalized after eating THC/CBD candies (20 mg THC and 10 mg CBD per candy), with doctors noting severe poisoning symptoms tied to dose and body weight. Medical cannabis market expansion: Curaleaf opened a new Cutler Bay, Florida dispensary on Sept. 1, adding to its growing Florida footprint and product lineup for patients. Cannabinoid product safety crackdown: Oneida County, New York, is tightening rules around synthetic cannabinoids sold in smoke shops, requiring accurate labeling of what’s actually inside. Clinical pipeline spotlight: Australian cannabinoid-focused Neurotech is back in focus for pediatric trials targeting autism spectrum disorder, with the market watching trial progress over cultivation stories. Hemp product innovation: UK firm Loxkin launched hemp-seed-oil-based wood finishes, positioning them as lower-VOC, solvent-free alternatives for furniture and home wood care. Cannabis industry access debate: A Rastafari leader in Antigua and Barbuda urged brethren still outside the law to join the regulated cannabis industry, arguing division is the biggest barrier to long-term gains. Local enforcement: Police in Narara, Australia seized cannabis plants and growing equipment in a home search, with a court notice expected for cultivation.
Medical Psilocybin Rollout: New Mexico opened medical psilocybin producer permit applications, moving the program from legislation to real operations for therapeutic use in conditions like treatment-resistant depression, PTSD, substance use disorders, and end-of-life care. Cannabis Consumer Access: A cannabis consumer advocacy booth debuted at the New York State Fair, pushing for better consumer data on product quality and safety as the industry grows. Medical Cannabis Policy & Politics: Rhode Island’s attorney general Democratic primary is turning personal, with candidates trading attacks over lead-safety compliance and allegations tied to cannabis retail licensing decisions. Public Health & Safety: A Canadian study found rural drivers are more likely than urban drivers to have alcohol, cannabis, and other impairing substances detected after crashes, suggesting prevention should target rural risk patterns. CBD/Cannabis in the Real World: An arrest report in Florida included marijuana possession and drug paraphernalia charges, underscoring how cannabis enforcement still shows up in everyday policing.
Medical Policy & Enforcement: A Wisconsin hemp shop owner says his arrest over “illegal THC” was racially motivated, arguing he only sold delta-9 products under the legal 0.3% threshold; he faces trafficking-related charges while stores reopen. Public Health & Crime Link: Malaysia’s anti-drug agency says drug offences are a “hub” that links to theft, violence and other crimes, with amphetamine-type stimulants dominating and cannabis far smaller in recent stats. CBD/THC in the Courts: A Coventry teen was charged after police found a knife and cannabis at Pool Meadow Bus Station, as officers ran citywide knife sweeps. Medical Cannabis Access Research: A study cited in coverage links medical cannabis access to fewer health-related work absences, adding to the growing debate over real-world outcomes. Drug-Use Risk Messaging: Turkey reporting highlights how substance use among youth is tied to long-running social neglect and disrupted services, with early use often before 17. Industry/Grants: Scotland renewed heritage CBD-related building support via a grants program aimed at preserving character properties, signaling continued niche investment around hemp/CBD-adjacent businesses.
Medical Cannabis Access: Alabama opened its second medical cannabis dispensary in Talladega, easing travel burdens for patients while the state moves toward 12 dispensaries under four companies. CBD/THC Research: Scientists report a new way THC may help slow breast cancer spread by pushing cancer cells toward a less aggressive state, using ultra-low-dose cannabinoid treatment in lab-grown tumor models. Topical CBD Product Watch: A UK retailer is promoting a fragrance-free CBD balm (CBD + CBG) marketed for joint and muscle comfort, positioned as a topical alternative to oils and gummies. Policy & Public Health: A guaranteed-income push is sparking debate in Texas, with lawmakers questioning whether pandemic-era cash assistance should become permanent—amid broader discussions of how states fund health and social programs. Legal/Criminal Justice (context): A Bronx judge found a NYC mother not criminally responsible for killing her two sons due to postpartum psychosis, a case drawing comparisons to the ongoing Lindsay Clancy trial.
Sign up for:
Medical Hemp Update
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.